A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...
Screening for prostate cancer becomes more complex in men over the age of 70. The US Preventive Services Task Force (USPSTF) currently recommends against routine PSA testing in this age group. The PSA ...
The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...
Add Yahoo as a preferred source to see more of our stories on Google. Thousands of men suffering from prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...
The phase 3 NRG GU-005 trial did not show a DFS benefit for SBRT vs IMRT in intermediate-risk prostate cancer, but SBRT decreased rectal toxicity. Stereotactic body radiation therapy (SBRT) preserves ...
Oct. 11 (UPI) --Former President Joe Biden has begun radiation therapy, in addition to hormone therapy, to treat aggressive prostate cancer, a spokesperson has confirmed. The radiation treatments will ...
This is what a frozen section of the prostate looks like. The researchers drilled small holes to extract tissue samples from areas where the gland contained cancer. It is precisely these tissue ...
New USC study identifies key genes linked to aggressive prostate cancer in people of African descent
New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results